Genomic Organization, Sequence Analysis and Transcriptional Regulation of the Human MCP-4 Chemokine Gene (SCYA13) in Dermal Fibroblasts: A Comparison to Other Eosinophilic β-Chemokines

The eosinophil chemotactic β-chemokine MCP-4 is assumed to be involved in the accumulation of eosinophils characteristic for eosinophilic inflammatory diseases. We here describe the genomic organisation (3 exons of 138, 115 and 578 bp, 2 introns of 867 and 437 bp and 1.4 kb of regulatory sequences from the immediate 5′ upstream region), sequence (genomic and transcribed) and mRNA expression of the human MCP-4 gene in dermal fibroblasts. Among the promoter elements potentially regulating MCP-4 gene expression and/or mediating the effects of anti-inflammatory drugs we identified consensus sequences known to interact with nuclear factors like NF-IL6, AP-2, a NF-κB like consensus sequence, γ-interferon- response and YY-1 elements as well as glucocorticoid response elements. Like MCP-3, MCP-4 mRNA expression in dermal fibroblasts is upregulated by TNF-α, IL-1α, IFN-γ or IL-4 and differs from RANTES and eotaxin mRNA expression in its response to IFN-γ and/or IL-4.